Employers Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.13M Hold
17,890
0.67% 47
2020
Q4
$1.11M Hold
17,890
0.67% 48
2020
Q3
$1.08M Sell
17,890
-5,125
-22% -$308K 0.73% 44
2020
Q2
$1.35M Buy
23,015
+5,475
+31% +$327K 0.76% 39
2020
Q1
$978K Buy
17,540
+5,065
+41% +$310K 0.68% 46
2019
Q4
$801K Hold
12,475
0.42% 69
2019
Q3
$633K Buy
12,475
+7,605
+156% +$357K 0.33% 81
2019
Q2
$221K Buy
+4,870
New +$227K 0.12% 126

Other funds holding BMY

Employers Holdings's BMY Position: Q1 2021 in Review

Employers Holdings held its Bristol-Myers Squibb (BMY) position steady in Q1 2021 at 17,890 shares worth $1.13M. The position accounts for 0.67% of the portfolio, ranked #47.

Employers Holdings first reported a position in BMY in Q2 2019 and has held it in 8 quarters since. The position peaked at $1.35M in Q2 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Employers Holdings held 17,890 shares of Bristol-Myers Squibb worth $1.13M as of Q1 2021.
  • Employers Holdings left its Bristol-Myers Squibb share count unchanged in Q1 2021.
  • Bristol-Myers Squibb made up 0.67% of Employers Holdings's portfolio in Q1 2021, its #47 holding.
  • Employers Holdings first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 8 quarters since.
  • Employers Holdings's Bristol-Myers Squibb position peaked at $1.35M in Q2 2020.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Employers Holdings's 13F filing for Q1 2021, filed 30 Apr 2021.